Skip to main content
TipRanks
Go Ultimate75% OFF

Yubo International Biotech (YBGJ) Stock Statistics & Valuation Metrics

13 Followers

Total Valuation

Yubo International Biotech has a market cap or net worth of $937.31K. The enterprise value is $867.54B.

Market Cap
$937.31K
Enterprise Value
$867.54B

Share Statistics

Yubo International Biotech has 170,416,340 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
170,416,340
Owned by Insiders
63.23%
Owned by Institutions
―

Financial Efficiency

Yubo International Biotech’s return on equity (ROE) is 0.55 and return on invested capital (ROIC) is 57.84%.

Return on Equity (ROE)
0.55
Return on Assets (ROA)
-1.27
Return on Invested Capital (ROIC)
57.84%
Return on Capital Employed (ROCE)
0.61
Revenue Per Employee
9,599.357
Profits Per Employee
-77.09K
Employee Count
14
Asset Turnover
0.16
Inventory Turnover
5.25

Valuation Ratios

The current PE Ratio of Yubo International Biotech is -0.96. Yubo International Biotech’s PEG ratio is -0.02.

PE Ratio
-0.96
PS Ratio
6.97
PB Ratio
-0.33
Price to FCF
-80.45
Price to Operating Cash Flow
-80.46
PEG Ratio
-0.02

Income Statement

In the last 12 months, Yubo International Biotech had revenue of 134.39K and earned -1.08M in profits. Earnings per share was -0.01.

Revenue
134.39K
Gross Profit
8,165
Operating Income
-1.19M
Pretax Income
-1.19M
Net Income
-1.08M
EBITDA
-1.01M
Earnings Per Share (EPS)
-0.01

Cash Flow

In the last 12 months, operating cash flow was -11.65K and capital expenditures 0, giving a free cash flow of -11.65K billion.

Operating Cash Flow
-11.65K
Free Cash Flow
-11.65K
Free Cash Flow per Share
-0.00

Dividends & Yields

Yubo International Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-1.24%
Earnings Yield
-90.20%

Stock Price Statistics

Beta
-0.16
52-Week Price Change
-28.57%
50-Day Moving Average
0.01
200-Day Moving Average
0.01
Relative Strength Index (RSI)
23.40
Average Volume (3m)
2,220

Financial Position

Yubo International Biotech as a current ratio of 0.24, with Debt / Equity ratio of -4.03%

Current Ratio
0.24
Quick Ratio
0.23
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.07
Interest Coverage Ratio
4887.64

Taxes

In the past 12 months, Yubo International Biotech has paid -108.69K in taxes.

Income Tax
-108.69K
Effective Tax Rate
0.09

Enterprise Valuation

Yubo International Biotech EV to EBITDA ratio is -0.96, with an EV/FCF ratio of -79.64.

EV to Sales
6.90
EV to EBITDA
-0.96
EV to Free Cash Flow
-79.64
EV to Operating Cash Flow
-79.64

Balance Sheet

Yubo International Biotech has $9,465.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $9,465.00 billion.

Cash & Marketable Securities
$9,465.00
Total Debt
$0.00
Net Cash
$9,465.00
Net Cash Per Share
$0.00
Tangible Book Value Per Share
-$0.02

Margins

Gross margin is 37.77%, with operating margin of -663.80%, and net profit margin of -629.09%.

Gross Margin
37.77%
Operating Margin
-663.80%
Pretax Margin
-690.69%
Net Profit Margin
-629.09%
EBITDA Margin
-722.11%
EBIT Margin
-779.31%

Analyst Forecast

The average price target for Yubo International Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
―
EPS Growth Forecast
―